Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,542,467
+$363,322 QoQ
Shares Held
1,286
+0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#2,745
of 4,605 holders
Holding Since
Sep 2022
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Peak Planning Group, LLC holds $3,165,308 across 5 Drug Manufacturers - General names. LLY ranks #1 (48.7% of the industry book) .
All Filings in LLY
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,542,467 | 1,286 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,179,145 | 1,282 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,368,067 | 1,273 | Shares | Sole | 2026-02-13 | |
| 2025-03-31 | $1,052,209 | 1,274 | Shares | Sole | 2026-06-24 | |
| 2024-12-31 | $961,140 | 1,245 | Shares | Sole | 2026-05-26 | |
| 2024-09-30 | $1,101,223 | 1,243 | Shares | Sole | 2026-06-24 | |
| 2024-06-30 | $1,135,346 | 1,254 | Shares | Sole | 2026-05-26 | |
| 2024-03-31 | $934,329 | 1,201 | Shares | Sole | 2026-05-26 | |
| 2023-12-31 | $694,257 | 1,191 | Shares | Sole | 2026-05-26 | |
| 2023-09-30 | $631,664 | 1,176 | Shares | Sole | 2026-05-26 | |
| 2023-06-30 | $551,520 | 1,176 | Shares | Sole | 2026-05-26 | |
| 2023-03-31 | $403,861 | 1,176 | Shares | Sole | 2026-05-26 | |
| 2022-12-31 | $430,227 | 1,176 | Shares | Sole | 2026-05-26 | |
| 2022-09-30 | $379,936 | 1,175 | Shares | Sole | 2026-05-26 | |
| No filing history on record for this holder in this stock. | ||||||